Larimar Therapeutics, Inc. (LRMR) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "LRMR"
      ],
      "issuer_cik": "0001374690",
      "owner_cik": "0001769848",
      "accession_number": "0001193125-26-459008",
      "form_type": "4",
      "filing_date": "2026-11-12",
      "period_of_report": "2026-11-12",
      "issuer_name": "Larimar Therapeutics, Inc.",
      "issuer_trading_symbol": "LRMR",
      "owner_name": "Hamilton Thomas Edward",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-11-12",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 70000,
      "transaction_price_per_share": 2.6726,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 70000,
      "transaction_value": 187082,
      "direct_or_indirect": "I",
      "nature_of_ownership": "Cure FA Foundation, Inc.",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $2.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."
        }
      ]
    },
    {
      "tickers": [
        "LRMR"
      ],
      "issuer_cik": "0001374690",
      "owner_cik": "0001377582",
      "accession_number": "0001193125-26-458834",
      "form_type": "4",
      "filing_date": "2026-11-12",
      "period_of_report": "2026-11-11",
      "issuer_name": "Larimar Therapeutics, Inc.",
      "issuer_trading_symbol": "LRMR",
      "owner_name": "Celano Michael",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Financial Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-11-11",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 18460,
      "transaction_price_per_share": 2.7081,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 234245,
      "transaction_value": 49991.526,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.695 to $2.715, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.